These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11257385)

  • 1. Vaccines and mucosal immunisation.
    Cripps AW; Kyd JM; Foxwell AR
    Vaccine; 2001 Mar; 19(17-19):2513-5. PubMed ID: 11257385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization: a realistic alternative.
    Otczyk DC; Cripps AW
    Hum Vaccin; 2010 Dec; 6(12):978-1006. PubMed ID: 21150284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for mucosal vaccine development.
    Boyaka PN; Marinaro M; Vancott JL; Takahashi I; Fujihashi K; Yamamoto M; van Ginkel FW; Jackson RJ; Kiyono H; McGhee JR
    Am J Trop Med Hyg; 1999 Apr; 60(4 Suppl):35-45. PubMed ID: 10344675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization: a review of strategies and challenges.
    Patel H; Yewale C; Rathi MN; Misra A
    Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in mucosal vaccine development.
    Chen H
    J Control Release; 2000 Jul; 67(2-3):117-28. PubMed ID: 10825547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery.
    Mishra N; Singh D; Sharma S; Baldi A
    Curr Drug Deliv; 2014; 11(6):729-43. PubMed ID: 25007830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.
    Nizard M; Diniz MO; Roussel H; Tran T; Ferreira LC; Badoual C; Tartour E
    Hum Vaccin Immunother; 2014; 10(8):2175-87. PubMed ID: 25424921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
    Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology solutions for mucosal immunization.
    Chadwick S; Kriegel C; Amiji M
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
    Denis F; Alain S; Ploy MC
    Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives in mucosal immunity with emphasis on vaccine development.
    McGhee JR; Fujihashi K; Xu-Amano J; Jackson RJ; Elson CO; Beagley KW; Kiyono H
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):3-12; discussion 13-5. PubMed ID: 8303308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunity: implications for vaccine development.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal formulations: promising strategy to deliver vaccines.
    Riese P; Sakthivel P; Trittel S; Guzmán CA
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.